Cardiopulmonary
As part of our ultimate mission to lead where medicine is going, we aspire to deliver transformational, accessible therapies that alter the course of cardiopulmonary diseases, providing patients with the chance for longer, healthier lives. This vision sets our direction toward growing an innovation mindset unlimited by the boundaries of our own walls.
To provide longer, healthier lives for the millions of people with cardiopulmonary diseases.
Focus areas
Our robust pipeline spans multiple focus areas with a number of programs in development, as well as select novel therapy programs recently approved, or with potential filings in the United States/European Union.